Russia Pharmaceutical Market Overview Pharma companies target Russia despite the challenges it presents

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Chemical and Pharmaceutical Plants Construction in Russia to 2018: Market Databook

Chemical and Pharmaceutical Plants Construction in Russia to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical and Pharmaceutical Plants Construction in Russia to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Russian Federation

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Arterium Corporation (Arterium) is a pharmaceutical company. The company develops, manufactures and markets pharmaceuticals, and antibacterial and herbal based medications. Its products include acelysin, acetylsalicylic acid, alteyca galychpharm, ambroxol, kanamycin, nicergolin, nifuroxazide, ...

Industries: Drug and Medication | Countries: Ukraine, Uzbekistan, Kazakhstan, Azerbaijan, Russian Federation, Belarus

Macleods Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

Macleods Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Philippines, Sri Lanka, Saudi Arabia, South Africa, Ukraine, Russian Federation, Vietnam, India, Benin

ReSearch Pharmaceutical Services, Inc. - Strategic SWOT Analysis Review

ReSearch Pharmaceutical Services, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

Summary ReSearch Pharmaceutical Services, Inc. (RPS) is a contract research organization. The company provides phase I-IV clinical development services to pharmaceutical, biotechnology and medical device industries. It offers services, such as analytical and product development, clinical operations, ...

Industries: Pharmaceutical | Countries: United States, Europe, Czech Republic, Netherlands, Ukraine, Sweden, Spain, Russian Federation, Portugal, Poland, Ireland, Hungary, France, Germany, Finland, Croatia, Bulgaria, Belgium, Austria, India, World

Pharmsynthez (LIFE) - Financial and Strategic SWOT Analysis Review

Pharmsynthez (LIFE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Pharmsynthez is a contract research and development company. The company carries out the research, manufacture, and distribution of generic active pharmaceutical ingredients (API). It provides official medicines such as Neovir, Segidrin, Fenasid and Penkrofton used to treat cancer, gynecology, ...

Industries: Pathology | Countries: Russian Federation, United States

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Veropharm is a pharmaceutical company. The company develops and manufactures generic pharmaceutical drugs, oncological medications, and medical adhesive bandages. It operates through three plants, such as Voronezh Chemical-Pharmaceutical Plant, Belgorod and Basil plant, and Pokrov ready-made ...

Industries: Drug and Medication | Countries: Russian Federation

Protek OAO (PRTK) - Financial and Strategic SWOT Analysis Review

Protek OAO (PRTK) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Protek is a pharmaceutical company. The company manufactures, sells and distributes pharmaceutical, health and beauty care products. Its products include CV Protek, Sotex Farm and Rigla Pharmacy Chain. Protek's CV Protek unit distributes pharmaceutical, health and beauty products. The company ...

Industries: Pharmaceutical | Countries: Russian Federation

Olainfarm (OLF1R) - Financial and Strategic SWOT Analysis Review

Olainfarm (OLF1R) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Olainfarm is a pharmaceutical company. The company manufactures oral dosage medicament forms, chemical ingredients and active pharmaceutical ingredients. It offers a wide range of prescription and non prescription drugs. Olainfarm offers prescription drugs, such as bikarfen, fenkarol, furagin, ...

Industries: Prescription Drug | Countries: Australia, Russian Federation, Latvia

Eisai GmbH SWOT Analysis, Strategy, Revenues and Profits

Eisai GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: Europe, Germany, Switzerland, Netherlands, United States, Sweden, Spain, Slovakia (slovak Republic), Russian Federation, Portugal, Norway, Italy, Ireland, France, Finland, Denmark, Austria, Japan, World

Genexine, Inc. (095700) - Financial and Strategic SWOT Analysis Review

Genexine, Inc. (095700) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Genexine, Inc. (Genexine) is a biotechnology company. The company develops and conducts research on therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as super-biosimilars. Its products include GX-E2 for Anemia, GX-G6 for Diabetes, GX-H9 for Dwarfism, ...

Industries: Drug and Medication | Countries: Brazil, Russian Federation, Thailand, South Korea, India

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.